Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock
CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.01−0.37 (-10.81%)
Close on Nov 17, 2026Market cap $58.22MP/E –Yield –
Corbus Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Corbus Pharmaceuticals's cash was $117.94M at Jun 30, 2026. For fiscal 2025 it was $163.27M, up 9.5% from the year before. Over ten years it grew 29.4% a year on average. The highest annual figure on record is $163.27M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $163.27M | +9.5% |
| FY2024 | Dec 31, 2024 | $149.06M | +613.0% |
| FY2023 | Dec 31, 2023 | $20.91M | -64.7% |
| FY2022 | Dec 31, 2022 | $59.20M | -39.4% |
| FY2021 | Dec 31, 2021 | $97.65M | +14.3% |
| FY2020 | Dec 31, 2020 | $85.43M | +169.1% |
| FY2019 | Dec 31, 2019 | $31.75M | -24.0% |
| FY2018 | Dec 31, 2018 | $41.75M | -33.4% |
| FY2017 | Dec 31, 2017 | $62.70M | +312.7% |
| FY2016 | Dec 31, 2016 | $15.19M | +22.8% |
| FY2015 | Dec 31, 2015 | $12.37M | +97.2% |
| FY2014 | Dec 31, 2014 | $6.28M | +1971.2% |
| FY2013 | Dec 31, 2013 | $303.02K | -44.1% |
| FY2012 | Dec 31, 2012 | $542.48K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $117.94M | +1.2% |
| Q1 FY2026 | Mar 31, 2026 | $138.22M | +4.1% |
| Q4 FY2025 | Dec 31, 2025 | $163.27M | +9.5% |
| Q3 FY2025 | Sep 30, 2025 | $103.98M | -34.8% |
| Q2 FY2025 | Jun 30, 2025 | $116.59M | -20.7% |
| Q1 FY2025 | Mar 31, 2025 | $132.79M | +10.6% |
| Q4 FY2024 | Dec 31, 2024 | $149.06M | +613.0% |
| Q3 FY2024 | Sep 30, 2024 | $159.36M | +454.6% |
| Q2 FY2024 | Jun 30, 2024 | $147.03M | +302.1% |
| Q1 FY2024 | Mar 31, 2024 | $120.10M | +171.6% |
| Q4 FY2023 | Dec 31, 2023 | $20.91M | -64.7% |
| Q3 FY2023 | Sep 30, 2023 | $28.73M | -56.6% |
| Q2 FY2023 | Jun 30, 2023 | $36.57M | -50.1% |
| Q1 FY2023 | Mar 31, 2023 | $44.23M | -48.6% |
| Q4 FY2022 | Dec 31, 2022 | $59.20M | -39.4% |
| Q3 FY2022 | Sep 30, 2022 | $66.23M | -38.0% |
| Q2 FY2022 | Jun 30, 2022 | $73.30M | -31.1% |
| Q1 FY2022 | Mar 31, 2022 | $86.12M | -30.6% |
| Q4 FY2021 | Dec 31, 2021 | $97.65M | +14.3% |
| Q3 FY2021 | Sep 30, 2021 | $106.86M | +30.5% |
| Q2 FY2021 | Jun 30, 2021 | $106.45M | +67.7% |
| Q1 FY2021 | Mar 31, 2021 | $124.01M | +166.0% |
| Q4 FY2020 | Dec 31, 2020 | $85.43M | +169.1% |
| Q3 FY2020 | Sep 30, 2020 | $81.87M | +49.3% |
| Q2 FY2020 | Jun 30, 2020 | $63.47M | -13.2% |
| Q1 FY2020 | Mar 31, 2020 | $46.62M | -48.2% |
| Q4 FY2019 | Dec 31, 2019 | $31.75M | -24.0% |
| Q3 FY2019 | Sep 30, 2019 | $54.85M | -1.5% |
| Q2 FY2019 | Jun 30, 2019 | $73.15M | +13.1% |
| Q1 FY2019 | Mar 31, 2019 | $89.92M | +26.7% |
| Q4 FY2018 | Dec 31, 2018 | $41.75M | -33.4% |
| Q3 FY2018 | Sep 30, 2018 | $55.66M | +51.3% |
| Q2 FY2018 | Jun 30, 2018 | $64.68M | +49.6% |
| Q1 FY2018 | Mar 31, 2018 | $70.96M | +44.4% |
| Q4 FY2017 | Dec 31, 2017 | $62.70M | +312.7% |
| Q3 FY2017 | Sep 30, 2017 | $36.80M | +92.7% |
| Q2 FY2017 | Jun 30, 2017 | $43.23M | – |
| Q1 FY2017 | Mar 31, 2017 | $49.13M | – |
| Q4 FY2016 | Dec 31, 2016 | $15.19M | – |
| Q3 FY2016 | Sep 30, 2016 | $19.10M | – |
See a number that looks wrong?